Insulin-like Growth Factor-I and Growth Differentiation Factor-5 Promote the Formation of Tissue-Engineered Human Nasal Septal Cartilage

被引:0
|
作者
Alexander, Thomas H. [1 ,2 ]
Sage, August B. [2 ]
Chen, Albert C. [3 ,4 ]
Schumacher, Barbara L. [2 ,3 ,4 ]
Shelton, Elliot [3 ,4 ]
Masuda, Koichi [3 ,4 ]
Sah, Robert L. [3 ,4 ]
Watson, Deborah [1 ,2 ]
机构
[1] Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA
[2] San Diego Vet Adm Med Ctr, San Diego, CA USA
[3] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Whitaker Inst Biomed Engn, San Diego, CA 92103 USA
关键词
BONE MORPHOGENETIC PROTEIN-2; CLONAL PROLIFERATION; CELL-DENSITY; HUMAN SERUM; CHONDROCYTES; ALGINATE; PHENOTYPE; COLLAGEN; CULTURE; REDIFFERENTIATION;
D O I
10.1089/ten.tec.2009.0396
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Introduction: Tissue engineering of human nasal septal chondrocytes offers the potential to create large quantities of autologous material for use in reconstructive surgery of the head and neck. Culture with recombinant human growth factors may improve the biochemical and biomechanical properties of engineered tissue. The objectives of this study were to (1) perform a high-throughput screen to assess multiple combinations of growth factors and (2) perform more detailed testing of candidates identified in part I. Methods: In part I, human nasal septal chondrocytes from three donors were expanded in monolayer with pooled human serum (HS). Cells were then embedded in alginate beads for 2 weeks of culture in medium supplemented with 2% or 10% HS and 1 of 90 different growth factor combinations. Combinations of insulin-like growth factor-I (IGF-1), bone morphogenetic protein (BMP)-2, BMP-7, BMP-13, growth differentiation factor-5 (GDF-5), transforming growth factor beta (TGF beta)-2, insulin, and dexamethasone were evaluated. Glycosaminoglycan (GAG) accumulation was measured. A combination of IGF-1 and GDF-5 was selected for further testing based on the results of part I. Chondrocytes from four donors underwent expansion followed by three-dimensional alginate culture for 2 weeks in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5. Chondrocytes and their associated matrix were then recovered and cultured for 4 weeks in 12mm transwells in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5 (the same medium used for alginate culture). Biochemical and biomechanical properties of the neocartilage were measured. Results: In part I, GAG accumulation was highest for growth factor combinations including both IGF-1 and GDF-5. In part II, the addition of IGF-1 and GDF-5 to 2% HS resulted in a 12-fold increase in construct thickness compared with 2% HS alone (p < 0.0001). GAG and type II collagen accumulation was significantly higher with IGF-1 and GDF-5. Confined compression modulus was greatest with 2% HS, IGF-1, and GDF-5. Conclusion: Supplementation of medium with IGF-1 and GDF-5 during creation of neocartilage constructs results in increased accumulation of GAG and type II collagen and improved biomechanical properties compared with constructs created without the growth factors.
引用
收藏
页码:1213 / 1221
页数:9
相关论文
共 50 条
  • [1] CARTILAGE AS A TARGET TISSUE FOR GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I
    ISAKSSON, OGP
    NILSSON, A
    ISGAARD, J
    LINDAHL, A
    ACTA PAEDIATRICA SCANDINAVICA, 1990, : 137 - 141
  • [2] Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary
    Vendola, K
    Zhou, J
    Wang, J
    Bondy, CA
    HUMAN REPRODUCTION, 1999, 14 (09) : 2328 - 2332
  • [3] INSULIN-LIKE GROWTH FACTOR-I IS AN AUTOCRINE GROWTH-FACTOR IN MYELOID DIFFERENTIATION
    ARKINS, S
    REBEIZ, N
    REESE, DL
    BIRAGYN, A
    KELLEY, KW
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A85 - A85
  • [4] Insulin-like Growth Factor-I and Slow, Bi-directional Perfusion Enhance the Formation of Tissue-Engineered Cardiac Grafts
    Cheng, Mingyu
    Moretti, Matteo
    Engelmayr, George C., Jr.
    Freed, Lisa E.
    TISSUE ENGINEERING PART A, 2009, 15 (03) : 645 - 653
  • [5] INSULIN AND INSULIN-LIKE GROWTH FACTOR-I STIMULATE CARTILAGE GROWTH AND MATRIX PROTEINS
    PASMANTIER, RM
    LEBOVITZ, HE
    CLINICAL RESEARCH, 1987, 35 (03): : A513 - A513
  • [6] Influence of insulin-like growth factor-I (IGF-I) on nerve autografts and tissue-engineered nerve grafts
    Fansa, H
    Schneider, W
    Wolf, G
    Keilhoff, G
    MUSCLE & NERVE, 2002, 26 (01) : 87 - 93
  • [7] REGULATION OF CARTILAGE GROWTH BY GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I
    ISAKSSON, OGP
    OHLSSON, C
    NILSSON, A
    ISGAARD, J
    LINDAHL, A
    PEDIATRIC NEPHROLOGY, 1991, 5 (04) : 451 - 453
  • [9] INSULIN-LIKE GROWTH FACTOR-I AND INSULIN AS GROWTH AND DIFFERENTIATION FACTORS IN CHICKEN EMBRYOGENESIS
    DEPABLO, F
    ROBCIS, HL
    CALDES, T
    ALEMANY, J
    SCAVO, L
    SERRANO, J
    POULTRY SCIENCE, 1991, 70 (08) : 1790 - 1796
  • [10] Insulin-like Growth Factor-I in Growth and Metabolism
    Backeljauw, P.
    Bang, P.
    Dunger, D. B.
    Juul, A.
    Le Bouc, Y.
    Rosenfeld, R.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (1-2): : 3 - 16